Publications

image2

  • Complexity, cost, and content - three important factors for translation of clinical protein mass spectrometry tests, and the case for apolipoprotein C-III proteoform testing, Clin Chem Lab Med. 2019 Dec 13, pii: /j/cclm.ahead-of-print/cclm-2019-0977/cclm-2019-0977.xml.
  • ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors, ATVB. 2019 Aug 8:ATVBAHA119312723. doi: 10.1161/ATVBAHA.119.312723
  • Top-down mass spectrometric immunoassay for human insulin and its therapeutic analogs, J Proteomics. 2018 Mar 20;175:27-33
  • Mass spectrometric studies of apolipoprotein proteoforms and their role in lipid metabolism and type 2 diabetes, Proteomes. 2017 Oct 15;5(4). pii: E27. doi: 10.3390/proteomes5040027
  • Human proteoforms as new targets for clinical mass spectrometry protein tests, Expert Rev Proteomics. 2017 Aug;14(8):691-699.
  • Mass spectrometry protein tests: Ready for primetime (or not), Expert Rev Proteomics. 2017 Jan;14(1):1-7.

Recent and Upcoming Conference Presentations

image3